SWOT Analysis for Inhibrx Biosciences Inc. - Threats

Add SWOT widget to your site/app

Relative Strength Index (RSI) Bullish

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Week

PE less than Industry PE

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

Stocks whose current price is 20% higher than week low, and more than previous close

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

New 52 week high today

Relative Outperformance versus Industry over 10 Years

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Companies with reducing Debt

Stock gained more than 20% in one month

Top Gainers

Stock with Low PE (PE < = 10)

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Stocks in the PE Sell Zone

Red Flag: Companies with weak Sloan Ratio

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Declining Net Cash Flow : Companies not able to generate net cash

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Stocks rising sharply on very low month volumes

MFs decreased their shareholding last quarter